Pressmeddelande

ChromoGenics communicates order data for the fourth quarter in 2023 and postpones publication of the year-end report for 2023.

Cision Publicerad: 16 Feb 16:00

ChromoGenics order intake for the fourth quarter 2023 amounted to 6,6 MSEK and the order book for the same period was 11,5 MSEK.

Due to unexpected administrative reasons, the Board of Directors of ChromoGenics has decided to postpone the publication of the year-end report for 2023 until 8^th of March 2024. Previously communicated date for submission of the report was on the 20^th of February 2024.

Full data on the fourth quarter 2023 will be published in the year-end report.

Contact:

Fredrik Fränding, CEO
Anne-Marie Gullman, CFO & Head of Investor Relations
Tel: +46 (0) 18 430 0430

E-mail: [email protected]

Bifogade filer

ChromoGenics publish orderdata and postpones submission of the year-end report for 2023https://mb.cision.com/Main/15418/3930548/2611227.pdf

Nyheter om ChromoGenics

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!